Hamilton Storage Announces Formation of Hamilton Storage GmbH
News Aug 07, 2015
Hamilton Storage has announced the formation of Hamilton Storage GmbH, a new company based in Malans, Switzerland. The initial staff of more than 40 employees will serve Hamilton Storage customers and prospects in Europe, the Middle East, Africa and Asia.
These territories were formerly managed under a distribution agreement with Hamilton Bonaduz AG, which also handles other Hamilton products.
The new organization gives Hamilton Storage a dedicated organization, including a development and deployment team, to sell and service its automated sample management products, many of which are custom systems for large applications.
“This new organization gives us more control and efficiency in serving our sample management customers, and will allow us to quickly expand our products and reach,” commented Matt Hamilton, president of Hamilton Storage. “We now have more dedicated resources and direct lines to our customers and prospects, and our sales engineers are now focused solely on sample management products. This enables us to deliver more products and better services to our customers.”
Hamilton Storage serves customers in biobanking, compound management, forensics, pharmaceutical and therapeutics development and clinical diagnostics. “Our new company is located in the middle of the Euro Zone, which is a key and growing market for Hamilton Storage,” continued Hamilton. “With this investment in a dedicated operation, we expect to see our business in these geographical areas grow significantly over the next several years.”
Cancer Cells’ Energy Source Blocked by Natural CompoundNews
Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.READ MORE
Drug Discovery Alliance Formed to Help Increase Drug Development Success RateNews
Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.READ MORE